Cl Pink Card Family Wellness Package at Chughtai Lab

Cl Pink Card Family at Chughtai Lab

The Cl Pink Card Family at Chughtai Lab represents a premier, highly comprehensive family wellness and preventive diagnostic screening package. Designed by leading healthcare professionals, this package serves as a proactive clinical tool to assess the overall health status of family members, facilitating the early detection of asymptomatic physiological imbalances, metabolic disorders, and chronic diseases. In Pakistan, the rising prevalence of non-communicable diseases (NCDs) such as type 2 diabetes mellitus, cardiovascular disease, hypertension, and chronic kidney disease underscores the critical clinical necessity of routine, multi-system screening. The Cl Pink Card Family package addresses this need by bundling essential laboratory investigations that evaluate key physiological systems, including the hematopoietic, cardiovascular, renal, hepatobiliary, and metabolic pathways.

This diagnostic package utilizes state-of-the-art laboratory technology to analyze blood and urine specimens, providing clinicians with highly accurate, reproducible data. By examining biomarkers such as complete blood counts, lipid profiles, renal clearance markers, liver transaminases, and urinary constituents, the Cl Pink Card Family package allows for a holistic assessment of a patient’s internal biochemistry. Early identification of subclinical abnormalities—such as borderline dyslipidemia, impaired fasting glucose, or early-stage renal impairment—enables timely therapeutic interventions, lifestyle modifications, and personalized medical management. Ultimately, this comprehensive screening package empowers families to take control of their health, reducing long-term morbidity and improving overall quality of life through evidence-based preventive medicine.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost clinical accuracy and prevent pre-analytical errors, patients must strictly adhere to the following preparation guidelines prior to specimen collection:

• Fasting Requirements: A strict fasting period of 8 to 12 hours is mandatory. Only plain water is permitted during this time. Fasting is essential for the accurate measurement of fasting blood glucose and lipid profiles, as recent food intake can artificially elevate triglycerides and glucose levels.
• Medication Disclosure: Patients must inform the phlebotomist and clinical staff of all ongoing prescription medications, over-the-counter drugs, vitamins, and herbal supplements. Certain medications can influence liver enzymes, renal markers, or hematological parameters. Do not discontinue prescribed medications unless explicitly instructed by your physician.
• Hydration: Adequate hydration with water is highly recommended. Being well-hydrated facilitates easier venous access, reduces patient discomfort during venipuncture, and prevents hemoconcentration, which can falsely elevate hematocrit and protein levels.
• Avoid Alcohol and Tobacco: Abstain from alcohol consumption and tobacco use for at least 24 to 48 hours prior to the test. Alcohol can acutely alter liver enzyme levels and triglyceride concentrations, while nicotine can affect cardiovascular parameters and blood glucose regulation.
• Physical Activity: Avoid strenuous physical exercise or intense workouts for 24 hours before specimen collection. Excessive physical exertion can temporarily elevate muscle enzymes (such as creatine kinase) and alter renal function markers.

During the Procedure

The specimen collection process for the Cl Pink Card Family package is conducted under strict aseptic conditions by certified, highly experienced phlebotomists at Chughtai Lab:

• Patient Positioning: The patient is comfortably seated in a specialized phlebotomy chair. The phlebotomist will ask the patient to confirm their identity using official identification and the registration receipt to ensure perfect sample tracking.
• Anatomical Site Selection: The phlebotomist inspects the patient’s arm, typically selecting a prominent vein in the antecubital fossa (the crease of the elbow), such as the median cubital vein.
• Aseptic Technique: A tourniquet is applied a few inches above the selected site to increase venous pressure and visibility. The site is thoroughly sanitized using a 70% isopropyl alcohol swab in a circular, outward motion and allowed to air dry completely to prevent hemolysis of the sample.
• Venipuncture and Sample Collection: Utilizing a sterile, single-use vacuum tube system (Vacutainer) and a fine-gauge needle, the phlebotomist performs the venipuncture. Blood is drawn into specific, color-coded tubes containing precise additives (such as EDTA for hematology, sodium fluoride for glucose, and clot activators for serum chemistry) in the medically recommended order of draw.
• Post-Puncture Care: Once the required volume of blood is collected, the needle is gently withdrawn, and immediate, direct pressure is applied to the puncture site with a sterile gauze pad to promote hemostasis and prevent hematoma formation. A hypoallergenic adhesive bandage is then applied.
• Urine Specimen Collection: If a urinalysis is included, the patient is provided with a sterile, labeled container and instructed on how to collect a clean-catch, midstream urine sample to minimize contamination from external skin flora.
• Duration and Safety: The entire blood collection process is completed within 5 to 10 minutes. All specimens are immediately labeled with unique barcodes at the patient’s bedside to guarantee absolute traceability and eliminate any risk of sample mix-ups.

When is a Cl Pink Card Family Performed?

Screening for Asymptomatic Metabolic Syndrome

Metabolic syndrome is a cluster of conditions—including elevated blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels—that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes. Because these conditions often develop silently without obvious symptoms, physicians frequently recommend the Cl Pink Card Family package as an annual screening tool. This comprehensive panel evaluates fasting blood glucose and lipid fractions, allowing clinicians to identify metabolic dysfunction early and implement preventive strategies before irreversible cardiovascular damage occurs.

Investigating Unexplained Lethargy and Microcytic Anemia

Chronic fatigue, weakness, dizziness, and pallor are common clinical complaints that warrant thorough investigation. These symptoms are frequently rooted in hematological deficiencies, such as iron-deficiency anemia or vitamin B12 deficiency, which impair the oxygen-carrying capacity of red blood cells. The Complete Blood Count (CBC) component of the Cl Pink Card Family package provides detailed quantitative data on hemoglobin levels, hematocrit, and red blood cell indices (MCV, MCH, MCHC). This allows physicians to diagnose the specific morphological type of anemia and initiate targeted nutritional or medical therapy.

Assessing Hepatobiliary Integrity and Fatty Liver Risk

Non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are highly prevalent in Pakistan, often associated with obesity and poor dietary habits. These conditions can progress silently to non-alcoholic steatohepatitis (NASH), cirrhosis, or hepatic failure. Physicians utilize the Liver Function Tests (LFTs) within this family package to monitor levels of transaminases (ALT, AST), alkaline phosphatase (ALP), and bilirubin. Elevated enzymes serve as sensitive biomarkers for hepatocyte injury, prompting early dietary interventions and medical management to preserve liver function.

Evaluating Renal Clearance and Glomerular Filtration

Chronic Kidney Disease (CKD) is a progressive, life-threatening condition that often remains asymptomatic until advanced stages. High blood pressure and diabetes are the primary drivers of renal damage. By measuring serum creatinine, blood urea nitrogen (BUN), and calculating the estimated Glomerular Filtration Rate (eGFR), the Cl Pink Card Family package provides a precise assessment of the kidneys’ filtration capacity. Urinalysis further screens for microalbuminuria or hematuria, allowing for the detection of early renal parenchymal disease when therapeutic interventions are most effective.

Monitoring Cardiovascular Risk and Lipid Profiles

Atherosclerotic cardiovascular disease remains a leading cause of mortality globally. High levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides, combined with low levels of high-density lipoprotein cholesterol (HDL-C), directly contribute to arterial plaque formation. Physicians request the lipid profile component of this package to calculate cardiovascular risk scores, guide lipid-lowering therapies (such as statins), and monitor the efficacy of dietary and lifestyle modifications in patients with a family history of premature coronary artery disease.

What Does a Cl Pink Card Family Detect?

The Cl Pink Card Family package is a powerful diagnostic tool capable of detecting a wide array of subclinical and clinical conditions. Through precise biochemical and hematological analysis, this package can identify:

• Iron-Deficiency Anemia: Characterized by low hemoglobin, low hematocrit, and microcytic, hypochromic red blood cell indices.
• Megaloblastic Anemia: Indicated by macrocytic red blood cells, often secondary to Vitamin B12 or folate deficiency.
• Infections and Inflammatory States: Detected via leukocytosis (elevated white blood cell count) or abnormal differential leukocyte counts.
• Thrombocytopenia: A low platelet count, which increases the clinical risk of bruising and spontaneous bleeding.
• Impaired Fasting Glucose (Prediabetes): Borderline elevated blood glucose levels indicating insulin resistance.
• Diabetes Mellitus: Persistently elevated fasting blood glucose levels meeting diagnostic thresholds.
• Hypercholesterolemia: Elevated total cholesterol levels, a key risk factor for coronary artery disease.
• Atherogenic Dyslipidemia: High levels of LDL-C combined with low levels of protective HDL-C.
• Hypertriglyceridemia: Elevated triglycerides, associated with metabolic syndrome and, at extreme levels, acute pancreatitis.
• Hepatocellular Injury: Elevated Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) indicating liver cell damage.
• Cholestasis or Biliary Obstruction: Elevated Alkaline Phosphatase (ALP) and bilirubin levels.
• Impaired Renal Filtration: Elevated serum creatinine and blood urea nitrogen (BUN) levels.
• Chronic Kidney Disease (CKD): Indicated by a reduced estimated Glomerular Filtration Rate (eGFR).
• Urinary Tract Infection (UTI): Detected via the presence of leukocytes, nitrites, and bacteria in the urine specimen.
• Renal Parenchymal Disease: Indicated by microscopic hematuria or proteinuria in the urinalysis.
• Dehydration: Suggested by elevated hematocrit, total protein, and specific gravity of urine.
• Nutritional Protein Deficiency: Indicated by low serum albumin and total protein levels.
• Gout Risk / Hyperuricemia: Elevated serum uric acid levels, which can lead to joint deposition or renal calculi.
• Electrolyte Imbalances: Abnormal levels of sodium, potassium, or chloride, crucial for cardiac and neuromuscular function.
• Subclinical Bone Disorders: Indicated by abnormal calcium and alkaline phosphatase levels.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized across Pakistan for its state-of-the-art diagnostic infrastructure, automated testing platforms, and rapid turnaround times. For routine hematological and biochemical investigations included in the Cl Pink Card Family package, specimens are processed with high efficiency. Most routine test results are finalized and verified by consultant pathologists within 6 to 12 hours of sample collection.

To ensure maximum convenience for patients and families, Chughtai Lab offers multiple seamless methods to access diagnostic reports. Once the results are verified, an automated SMS notification containing a direct download link is sent to the patient’s registered mobile number. Patients can securely access, view, and download their reports in PDF format via the official Chughtai Lab website (www.chughtailab.com) by entering their unique case number and password printed on the patient receipt. Furthermore, the Chughtai Lab Mobile App, available on iOS and Android platforms, provides a comprehensive portal where patients can track their laboratory history, compare past results, and share reports directly with their consulting physicians. Hard copies of the reports can also be collected at any time from the nearest Chughtai Lab collection center.

Cl Pink Card Family Findings Overview

The following table provides a general overview of the primary parameters evaluated in the Cl Pink Card Family package, along with typical normal ranges and potential clinical implications of abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hemoglobin (Hb)	Male: 13.5–17.5 g/dL Female: 12.0–15.5 g/dL	Low: Anemia (iron deficiency, chronic disease) High: Polycythemia, severe dehydration
White Blood Cell (WBC) Count	4,500–11,000 cells/mcL	Low: Leukopenia (viral infections, bone marrow issues) High: Leukocytosis (acute infection, inflammation)
Fasting Blood Glucose	70–99 mg/dL	Low: Hypoglycemia High: Prediabetes (100-125 mg/dL), Diabetes (≥126 mg/dL)
Total Cholesterol	<200 mg/dL	High: Hypercholesterolemia, increased cardiovascular risk
Serum Creatinine	Male: 0.6–1.2 mg/dL Female: 0.5–1.1 mg/dL	High: Renal impairment, acute kidney injury, chronic kidney disease
Alanine Aminotransferase (ALT)	<45 U/L	High: Hepatocellular damage, fatty liver, hepatitis, drug-induced liver injury
Urine Protein	Negative / Trace	Positive: Proteinuria, early diabetic nephropathy, glomerular disease
Serum Uric Acid	Male: 3.4–7.0 mg/dL Female: 2.4–6.0 mg/dL	High: Hyperuricemia, gout, increased risk of renal stones

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Cl Pink Card Family?

• ISO 15189 Certified Laboratories: Chughtai Lab adheres to stringent international standards of quality, competence, and analytical accuracy in diagnostic testing.
• Advanced Automated Technology: Utilizing state-of-the-art, fully automated biochemistry and hematology analyzers to minimize human error and ensure precise results.
• Pathologist-Supervised Reporting: All complex diagnostic profiles and abnormal findings are thoroughly reviewed and signed off by qualified Consultant Pathologists.
• Convenient Home Sample Collection: Offering highly professional, hygienic phlebotomy services at your doorstep across major cities in Pakistan.
• Extensive Nationwide Network: With over 300 collection centers across Pakistan, accessing quality diagnostic care is highly convenient for your entire family.
• Secure Digital Portal and Mobile App: Seamless, 24/7 online access to electronic medical records, historical test comparisons, and downloadable PDF reports.
• Strict Quality Control Protocols: Regular participation in international external quality assessment schemes (EQAS) and rigorous daily internal quality checks.
• Patient-Centric Care and Support: Dedicated customer support, comfortable and hygienic environments at all diagnostic centers, and a commitment to compassionate patient care.